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We have developed a new probe for histochemical demonstration of prolactin binding sites. Ovine prolactin (oPRL) was conjugated with the N-hydroxy-succinimide ester derivafive of the fluorocb.rome 7-amino-4-methylcoumarin.3-acetic acid.
Under mild reaction conditions the ester derivative reacted with available NH2 groups of the prolactin molecule to form stable bonds. The coupling reaction yielded products that co-migrated with oPRL but had slightly decreased isoelectric points. The receptor binding and bioac-
Introduction
The adenohypophyseal hormone prolactin (PRL) exerts its actions by an initial interaction with plasma membrane receptor proteins on target cells (1). A large body ofliterature documents the distribution of these receptors in a variety of organs of many species (2 were stored desiccated at -70'C for up to 1 month.
Membrane fractions
were prepared from livers according to the procedure of Drake and Friesen (17) .
Briefly, livers were homogenized in 0.3 M sucrose containing 0.1% bacitracin and centrifuged at 1500 x g at 4 C for 20 mm. The supernatant was centrifuged at 15,000 x g at 4'C for 20 mm and the pellet discarded.
The second supernatant was then centrifuged at 100,000 x g at 4'C for 90 mm. The final pellet was re-suspended in 10 mM Hepes, pH 7.6, con- and 9 M urea. The gels were run overnight at 500 V and then stained with Coomassie blue.
Radioreceptor Assay and Bioassay. RRAs using liver membrane preparations from lactating rats were conducted as described previously (14) . Approximately 400 ig membrane protein was used per RRA assay tube. Radioiodination of oPRL using 1251 (Amersham Corporation;
Arlington Heights, IL) was achieved by our modification of the chloramine-T procedure, as described previously (21) . Before each experiment, the labeled ligand was BSA for 30 mm. All histochemical studies described in this report were accomplished using a probe with a s:i F:P ratio. For total binding, tissues were incubated with the AMCA-OPRL probe at concentrations of 10-200 nM. For nonspecific binding, unlabeled hormones were co-incubated with the probe at a concentration of 5 MM. All incubations were done in a humidified chamber for 4 hr at room temperature.
At the conclusion of incubation the slides were exhaustively washed with the same buffer and cover- Details on the bioassay protocol, maintenance, and synchronization of cells are given in Materials and Methods. Note: the preparation with the 10:1 F:P ratio was completely devoid of biological activity in the Nb2 lymphoma bioassay.
slipped. The sections were viewed with a Zeiss standard microscope equipped for transmitted darkfield illumination, using a LP-410 barrier filter. Photographs were taken on KOdak Technical Pan 2415 developed in D-19 for4 mm.
Results
' Table  1 illustrates the relation between the F:P ratio of the products and their biological and receptor binding activities.
As seen in Figure  1 , addition of up to 10 molecules of AMCA and immunoreactivity. Figure  3 shows the receptor binding activity ofthe different derivatives, as measured in competitive binding assays using liver membrane preparations. The derivatives with 3:1 and iOi F:P ratios showed the least ability to displace ['251J.oPRL from its binding sites. However, those products that showed no change in their IEPs, the ii and 51 F:P ratio products, were equipotent with oPRL in our RRAs. Similarly, the preparations with the lowest IEPs also had the lowest biopotency (the bioactivity of the 3:1 F:P product was one order of magnitude lower than that ofoPRL, while io:i F:P product was devoid ofbioactivity), as measured by their ability to induce Nb2 lymphoma cell proliferation in vitro ( Figure  4) . Similarly, the 31 and io:i F:P products showed the lowest immunoreactivities (data not shown). The AMCA-conjugated oPRL probes with higher F:P ratios were suitable for labeling of PRL binding sites both in the mammary gland and brain. As seen in Figure 5 , PM. binding in the mammary gland of lactating rats appeared to parallel the cell profiles.
The same pattern of binding was observed in the brain (Figure 6 ). Cells of the choroid plexus of the lateral ventricles and the epen- the ion front ( Figure  2B, lanes 2-5) 
